BlackRock Investment Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$15.5M Buy
137,462
+24,012
+21% +$2.78M 0.02% 838
2016
Q3
$14.6M Buy
113,450
+1,480
+1% +$177K 0.02% 772
2016
Q2
$12.2M Sell
111,970
-125,843
-53% -$12.5M 0.02% 832
2016
Q1
$22.5M Buy
237,813
+81,150
+52% +$6.85M 0.03% 514
2015
Q4
$14.1M Buy
156,663
+1,232
+0.8% +$105K 0.02% 740
2015
Q3
$14.4M Sell
155,431
-2,380
-2% -$210K 0.02% 709
2015
Q2
$10.4M Buy
157,811
+27,340
+21% +$1.82M 0.01% 991
2015
Q1
$9.34M Buy
130,471
+2,113
+2% +$115K 0.01% 994
2014
Q4
$4.88M Sell
128,358
-1,123
-0.9% -$35.4K 0.01% 1373
2014
Q3
$3.21M Buy
129,481
+988
+0.8% +$25K ﹤0.01% 1656
2014
Q2
$3.23M Buy
128,493
+2,075
+2% +$48.3K ﹤0.01% 1715
2014
Q1
$3.29M Buy
126,418
+1,018
+0.8% +$28.2K ﹤0.01% 1693
2013
Q4
$3.35M Sell
125,400
-2,121
-2% -$52.4K 0.01% 1640
2013
Q3
$2.43M Buy
127,521
+7,011
+6% +$160K ﹤0.01% 1812
2013
Q2
$2.6M Buy
+120,510
New +$2.42M ﹤0.01% 1667

Other funds holding ABMD

BlackRock Investment Management's ABMD Position: Q4 2016 in Review

BlackRock Investment Management increased its Abiomed Inc (ABMD) stake by 21% in Q4 2016, buying an estimated $2.78M and bringing the position to 137,462 shares worth $15.5M. The position accounts for 0.02% of the portfolio, ranked #838.

BlackRock Investment Management first reported a position in ABMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $22.5M in Q1 2016. 297 funds tracked by Wall St. Rank hold ABMD as of Q4 2016.

  • BlackRock Investment Management held 137,462 shares of Abiomed Inc worth $15.5M as of Q4 2016.
  • BlackRock Investment Management bought 24,012 Abiomed Inc shares in Q4 2016, an estimated $2.78M.
  • Abiomed Inc made up 0.02% of BlackRock Investment Management's portfolio in Q4 2016, its #838 holding.
  • BlackRock Investment Management first reported a position in Abiomed Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Abiomed Inc position peaked at $22.5M in Q1 2016.
  • 297 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.